EGFR and lung carcinoma: Detection of epidermal growth factor receptor (EGFR) [13], epithelial-to-mesenchymal transition (EMT) mutation, exosomes, bone resorption stimulating factor (BRSF) and analysis of ALK, ROS1, RET and NTRK translocation have been incorporated into the diagnosis or treatment of lung cancer [1,5,14].